story of the week
Survival Outcomes in Older Men With Non–Metastatic Castration-Resistant Prostate Cancer Treated With Androgen Receptor Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Survival Outcomes in Older Men With Non-Metastatic Castration-Resistant Prostate Cancer Treated With Androgen Receptor Inhibitors: A US Food and Drug Administration Pooled Analysis of Patient-Level Data From Three Randomised Trials
Lancet Oncol 2021 Jul 23;[EPub Ahead of Print], J Fallah, L Zhang, A Amatya, Y Gong, B King-Kallimanis, V Bhatnagar, C Weinstock, DL Suzman, S Agrawal, E Chang, MS Anscher, DC Chi, JX Xu, JR Brewer, MH Brave, M Hadadi, MR Theoret, PG Kluetz, KB Goldberg, A Ibrahim, S Tang, R Pazdur, JA Beaver, L Amiri-Kordestani, H SinghFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.